Dendritic cell subsets in the maintenance of gut health and response to bioactives

树突状细胞亚群在维持肠道健康和对生物活性物质的反应中的作用

基本信息

  • 批准号:
    BB/I005609/1
  • 负责人:
  • 金额:
    $ 49.4万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2010
  • 资助国家:
    英国
  • 起止时间:
    2010 至 无数据
  • 项目状态:
    已结题

项目摘要

In order to maintain human health, it is vital that harmful pathogens that enter the body (such as bacteria and viruses) are quickly eliminated by the immune system. However, immune responses must be carefully controlled so that they are only activated at an appropriate time. If this tight regulation is disrupted, the immune system can potentially attack and damage the organs and tissue of the body, resulting in so-called 'autoimmune disease'. Similarly, allergies can result if the immune system is activated in response to normally harmless substances, such as metal in jewellery or food substances. A particularly critical area of the body for immune regulation is the intestine. The intestine is lined with trillions of bacteria which are important in maintaining normal health, but could potentially trigger an immune response causing inflammatory bowel disease. Similarly, as food substances pass through the intestine, they could also potentially trigger immune activation in the absence of tight control, resulting in food allergy. Therefore, understanding the cells and molecules that control activation of the immune system is paramount if we are going to understand how our immune system functions to maintain normal health. In the food industry, there is great interest in the design of foodstuffs that can actively promote human health (so called 'bioactives'), especially in the gut. For example, many dairy products and drinks contain so-called 'probiotics', which are live bacteria intended to enhance gut health. However, the mechanisms by which bioactives enhance gut health are ill defined, and often there is mistrust from the public in manufacturer's claims that their products will improve health. Therefore, it is essential to understand how bioactives affect the biology of the gut to promote health, to provide important read-outs that can be used to scientifically assess existing and novel bioactives. The only way that enhancement of gut health will be achieved is by increasing our basic understanding of the cells and molecules that maintain and promote normal gut health. As immune regulation is critical in maintaining a healthy gut, understanding how immune responses in the intestine are regulated will be critical in identifying potentially beneficial effects of bioactives. An important cell type involved in regulating all immune responses is the dendritic cell (DC). Our laboratories have recently shown, using mouse models, that important subsets of DC present in the intestine are critical in maintenance of gut health. These DC subsets are characterised by the expression of different proteins on their surface, called CD103 and integrin alphav beta8, and by their ability to produce important molecules called TGF-beta and retinoic acid. The DC promote immune regulation by inducing an immune cell type called 'regulatory T-cells', which are important cells in preventing harmful immune reactions. To build on our mouse studies, it is now critical to identify the role of these specialised DCs in human gut health. Our proposal will characterise these specialised DCs, in terms of the protein markers and molecules they express and how they function in healthy humans. We will go on to identify how known bioactives affect the biology of these DC subsets. This work will therefore identify important cells and pathways that are central to the maintenance of gut health, provide novel data on the how known bioactives work, and identify read-outs by which novel bioactive food substances can be scientifically evaluated for potential beneficial effects on the gut.
为了维持人类健康,免疫系统迅速清除进入人体的有害病原体(如细菌和病毒)是至关重要的。然而,必须仔细控制免疫反应,以便只在适当的时间激活它们。如果这种严密的调节被打乱,免疫系统可能会攻击和破坏身体的器官和组织,导致所谓的“自身免疫性疾病”。同样,如果免疫系统对正常无害的物质(如珠宝中的金属或食品中的物质)做出反应时被激活,也会导致过敏。肠道是人体免疫调节的一个特别关键的区域。肠道内有数万亿种细菌,这些细菌对维持正常健康很重要,但可能会引发免疫反应,导致炎症性肠病。同样,当食物物质通过肠道时,它们也可能在没有严格控制的情况下触发免疫激活,导致食物过敏。因此,如果我们要了解我们的免疫系统如何运作以维持正常健康,了解控制免疫系统激活的细胞和分子是至关重要的。在食品工业中,人们对能够积极促进人类健康的食品(即所谓的生物活性物质)的设计非常感兴趣,特别是在肠道中。例如,许多乳制品和饮料含有所谓的“益生菌”,这是一种活细菌,旨在促进肠道健康。然而,生物活性物质促进肠道健康的机制还不清楚,而且制造商声称他们的产品将改善健康的说法经常受到公众的不信任。因此,了解生物活性物质如何影响肠道生物学以促进健康,提供可用于科学评估现有和新的生物活性物质的重要读数是至关重要的。增强肠道健康的唯一方法是增加我们对维持和促进正常肠道健康的细胞和分子的基本了解。由于免疫调节对维持健康的肠道至关重要,因此了解肠道中的免疫反应是如何调节的,对于确定生物活性物质的潜在益处至关重要。参与调节所有免疫反应的一种重要细胞类型是树突状细胞(DC)。我们的实验室最近使用小鼠模型表明,肠道中存在的DC的重要亚群对维持肠道健康至关重要。这些DC亚群的特征是在其表面表达不同的蛋白质,称为CD103和整合素α-β8,以及它们产生重要分子的能力,称为转化生长因子-β和维甲酸。树突状细胞通过诱导一种称为“调节性T细胞”的免疫细胞类型来促进免疫调节,这种细胞是防止有害免疫反应的重要细胞。为了在我们的小鼠研究的基础上,现在至关重要的是确定这些专门的DC在人类肠道健康中的作用。我们的提案将根据它们表达的蛋白质标志物和分子以及它们在健康人类中的功能来表征这些专门的DC。我们将继续确定已知的生物活性如何影响这些DC亚群的生物学。因此,这项工作将确定对维持肠道健康至关重要的重要细胞和途径,提供有关已知生物活性物质如何工作的新数据,并确定读数,通过这些读数可以科学地评估新的生物活性食品物质对肠道的潜在有益影响。

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hermansky-Pudlak syndrome type 1 causes impaired anti-microbial immunity and inflammation due to dysregulated immunometabolism.
  • DOI:
    10.1038/s41385-022-00572-1
  • 发表时间:
    2022-06
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Cavounidis, Athena;Pandey, Sumeet;Capitani, Melania;Friedrich, Matthias;Cross, Amy;Gartner, Lisa;Aschenbrenner, Dominik;Kim-Schulze, Seunghee;Lam, Ying Ka;Berridge, Georgina;McGovern, Dermot P. B.;Kessler, Benedikt;Fischer, Roman;Klenerman, Paul;Hester, Joanna;Issa, Fadi;Torres, Esther A.;Powrie, Fiona;Gochuico, Bernadette R.;Gahl, William A.;Cohen, Louis;Uhlig, Holm H.
  • 通讯作者:
    Uhlig, Holm H.
ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation.
  • DOI:
    10.7554/elife.10066
  • 发表时间:
    2016-01-18
  • 期刊:
  • 影响因子:
    7.7
  • 作者:
    Pearson C;Thornton EE;McKenzie B;Schaupp AL;Huskens N;Griseri T;West N;Tung S;Seddon BP;Uhlig HH;Powrie F
  • 通讯作者:
    Powrie F
The alarmin IL-33 promotes regulatory T-cell function in the intestine.
  • DOI:
    10.1038/nature13577
  • 发表时间:
    2014-09-25
  • 期刊:
  • 影响因子:
    64.8
  • 作者:
    Schiering, Chris;Krausgruber, Thomas;Chomka, Agnieszka;Froehlich, Anja;Adelmann, Krista;Wohlfert, Elizabeth A.;Pott, Johanna;Griseri, Thibault;Bollrath, Julia;Hegazy, Ahmed N.;Harrison, Oliver J.;Owens, Benjamin M. J.;Loehning, Max;Belkaid, Yasmine;Fallon, Padraic G.;Powrie, Fiona
  • 通讯作者:
    Powrie, Fiona
Induced pluripotent stem cell derived macrophages as a cellular system to study salmonella and other pathogens.
  • DOI:
    10.1371/journal.pone.0124307
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Hale C;Yeung A;Goulding D;Pickard D;Alasoo K;Powrie F;Dougan G;Mukhopadhyay S
  • 通讯作者:
    Mukhopadhyay S
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model.
  • DOI:
    10.1084/jem.20122308
  • 发表时间:
    2013-05-06
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kirchberger S;Royston DJ;Boulard O;Thornton E;Franchini F;Szabady RL;Harrison O;Powrie F
  • 通讯作者:
    Powrie F
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Fiona Powrie其他文献

Dendritic-cell genealogy
树突状细胞谱系
  • DOI:
    10.1038/462732a
  • 发表时间:
    2009-12-09
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Sophie Laffont;Fiona Powrie
  • 通讯作者:
    Fiona Powrie
Regulatory T cells in the control of immune pathology
调节性 T 细胞在免疫病理控制中的作用
  • DOI:
    10.1038/ni0901-816
  • 发表时间:
    2001-09-01
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Kevin J. Maloy;Fiona Powrie
  • 通讯作者:
    Fiona Powrie
OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset [published erratum appears in J Exp Med 1991 Apr 1;173(4):1037]
OX-22high CD4 T 细胞诱导多器官病理消耗性疾病:通过 OX-22low 亚群进行预防[已发表的勘误表出现在 J Exp Med 1991 年 4 月 1 日;173(4):1037]
Autoimmunity in inflammatory bowel disease: a holobiont perspective
炎症性肠病中的自身免疫:一个共生功能体视角
  • DOI:
    10.1016/j.coi.2025.102557
  • 发表时间:
    2025-06-01
  • 期刊:
  • 影响因子:
    5.800
  • 作者:
    Henry Taylor;Holm H Uhlig;Fiona Powrie
  • 通讯作者:
    Fiona Powrie
Memory CD4+ T cells in man form two distinct subpopulations, defined by their expression of isoforms of the leucocyte common antigen, CD45.
人类的记忆 CD4 T 细胞形成两个不同的亚群,由它们白细胞共同抗原 CD45 亚型的表达来定义。
  • DOI:
  • 发表时间:
    1990
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Don Mason;Fiona Powrie
  • 通讯作者:
    Fiona Powrie

Fiona Powrie的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Fiona Powrie', 18)}}的其他基金

Mouse genetic models of barrier immunity dysfunction: Role of the microbiome in modifying disease phenotype
屏障免疫功能障碍的小鼠遗传模型:微生物组在改变疾病表型中的作用
  • 批准号:
    MC_PC_21045
  • 财政年份:
    2022
  • 资助金额:
    $ 49.4万
  • 项目类别:
    Research Grant
MICA: Tissue ecology in IBD-development and pathophysiological function
MICA:IBD 发展和病理生理功能中的组织生态学
  • 批准号:
    MR/W025981/1
  • 财政年份:
    2022
  • 资助金额:
    $ 49.4万
  • 项目类别:
    Research Grant
Pathfinder: Defining interactions between the cytokine IL-22 and oncogenic KRAS as a new therapeutic target in colorectal cancer
探路者:将细胞因子 IL-22 和致癌 KRAS 之间的相互作用定义为结直肠癌的新治疗靶点
  • 批准号:
    MR/N02690X/1
  • 财政年份:
    2016
  • 资助金额:
    $ 49.4万
  • 项目类别:
    Research Grant

相似国自然基金

全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
  • 批准号:
    QN25H220002
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    15.0 万元
  • 项目类别:
    省市级项目
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
  • 批准号:
    82305053
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
  • 批准号:
    82371799
  • 批准年份:
    2023
  • 资助金额:
    47.00 万元
  • 项目类别:
    面上项目
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
  • 批准号:
    82371145
  • 批准年份:
    2023
  • 资助金额:
    46.00 万元
  • 项目类别:
    面上项目
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
  • 批准号:
    82370923
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目

相似海外基金

Understanding Dysregulated Crosstalk Between Regulatory T Cells and Lung Dendritic Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease
了解慢性阻塞性肺疾病发病机制中调节性 T 细胞和肺树突状细胞之间的失调串扰
  • 批准号:
    10460830
  • 财政年份:
    2022
  • 资助金额:
    $ 49.4万
  • 项目类别:
Engineering dendritic cells to target islet antigen to pro-tolerogenic subsets for prevention and treatment of Type 1 Diabetes
工程树突状细胞将胰岛抗原靶向促耐受性亚群,用于预防和治疗 1 型糖尿病
  • 批准号:
    10436038
  • 财政年份:
    2022
  • 资助金额:
    $ 49.4万
  • 项目类别:
Engineering dendritic cells to target islet antigen to pro-tolerogenic subsets for prevention and treatment of Type 1 Diabetes
工程树突状细胞将胰岛抗原靶向促耐受性亚群,用于预防和治疗 1 型糖尿病
  • 批准号:
    10595602
  • 财政年份:
    2022
  • 资助金额:
    $ 49.4万
  • 项目类别:
Understanding Dysregulated Crosstalk Between Regulatory T Cells and Lung Dendritic Cells in the Pathogenesis of Chronic Obstructive Pulmonary Disease
了解慢性阻塞性肺疾病发病机制中调节性 T 细胞和肺树突状细胞之间的失调串扰
  • 批准号:
    10746742
  • 财政年份:
    2022
  • 资助金额:
    $ 49.4万
  • 项目类别:
Toward safe, systemic immunotherapies for treatment of metastatic disease: Developing dendritic cell-biased immunomodulators with precise control over magnitude and timing of immune stimulation
实现治疗转移性疾病的安全、系统性免疫疗法:开发树突状细胞偏向的免疫调节剂,精确控制免疫刺激的幅度和时间
  • 批准号:
    10305471
  • 财政年份:
    2021
  • 资助金额:
    $ 49.4万
  • 项目类别:
Antigen-specific ‘kick and kill’ of the latent HIV reservoir using dendritic cells
使用树突状细胞对潜伏 HIV 病毒库进行抗原特异性“踢杀”
  • 批准号:
    10401605
  • 财政年份:
    2021
  • 资助金额:
    $ 49.4万
  • 项目类别:
Antigen-specific ‘kick and kill’ of the latent HIV reservoir using dendritic cells
使用树突状细胞对潜伏 HIV 病毒库进行抗原特异性“踢杀”
  • 批准号:
    10521310
  • 财政年份:
    2021
  • 资助金额:
    $ 49.4万
  • 项目类别:
Toward safe, systemic immunotherapies for treatment of metastatic disease: Developing dendritic cell-biased immunomodulators with precise control over magnitude and timing of immune stimulation
实现治疗转移性疾病的安全、系统性免疫疗法:开发树突状细胞偏向的免疫调节剂,精确控制免疫刺激的幅度和时间
  • 批准号:
    10468316
  • 财政年份:
    2021
  • 资助金额:
    $ 49.4万
  • 项目类别:
Toward safe, systemic immunotherapies for treatment of metastatic disease: Developing dendritic cell-biased immunomodulators with precise control over magnitude and timing of immune stimulation
实现治疗转移性疾病的安全、系统性免疫疗法:开发树突状细胞偏向的免疫调节剂,精确控制免疫刺激的幅度和时间
  • 批准号:
    10818663
  • 财政年份:
    2021
  • 资助金额:
    $ 49.4万
  • 项目类别:
Regulation and function of nonlymphoid organ CD103+ dendritic cells
非淋巴器官CD103树突状细胞的调节和功能
  • 批准号:
    10469028
  • 财政年份:
    2021
  • 资助金额:
    $ 49.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了